These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients. Schubert S, Abdul-Khaliq H, Lehmkuhl HB, Yegitbasi M, Reinke P, Kebelmann-Betzig C, Hauptmann K, Gross-Wieltsch U, Hetzer R, Berger F. Pediatr Transplant; 2009 Feb; 13(1):54-62. PubMed ID: 18518912 [Abstract] [Full Text] [Related]
7. Epidemiology of pretransplant EBV and CMV serostatus in relation to posttransplant non-Hodgkin lymphoma. Opelz G, Daniel V, Naujokat C, Döhler B. Transplantation; 2009 Oct 27; 88(8):962-7. PubMed ID: 19855238 [Abstract] [Full Text] [Related]
8. Risk factors associated with cytomegalovirus-positive antigenemia in orthotopic liver transplant patients. Hoppe L, Bressane R, Lago LS, Schiavo FL, Marroni CA, Keiserman DR, Brandão AB, Júnior AM, Cassal AP, Zanotelli ML, Cantisani GP. Transplant Proc; 2004 May 27; 36(4):961-3. PubMed ID: 15194334 [Abstract] [Full Text] [Related]
9. Antiviral prophylaxis and the Epstein Barr virus-related post-transplant lymphoproliferative disorder. Davis CL, Harrison KL, McVicar JP, Forg PJ, Bronner MP, Marsh CL. Clin Transplant; 1995 Feb 27; 9(1):53-9. PubMed ID: 7742583 [Abstract] [Full Text] [Related]
14. Posttransplantation lymphoproliferative disorder in pediatric liver transplantation. Heo JS, Park JW, Lee KW, Lee SK, Joh JW, Kim SJ, Lee HH, Lee DS, Choi SH, Seo JM, Choe YH. Transplant Proc; 2004 Oct 27; 36(8):2307-8. PubMed ID: 15561231 [Abstract] [Full Text] [Related]
15. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients. Schubert S, Renner C, Hammer M, Abdul-Khaliq H, Lehmkuhl HB, Berger F, Hetzer R, Reinke P. J Heart Lung Transplant; 2008 Jan 27; 27(1):100-5. PubMed ID: 18187094 [Abstract] [Full Text] [Related]
16. Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients. Zangwill SD, Hsu DT, Kichuk MR, Garvin JH, Stolar CJ, Haddad J, Stylianos S, Michler RE, Chadburn A, Knowles DM, Addonizio LJ. J Heart Lung Transplant; 1998 Dec 27; 17(12):1161-6. PubMed ID: 9883755 [Abstract] [Full Text] [Related]
17. Epstein-Barr virus seronegativity is a risk factor for late-onset posttransplant lymphoroliferative disorder in adult renal allograft recipients. Shahinian VB, Muirhead N, Jevnikar AM, Leckie SH, Khakhar AK, Luke PP, Rizkalla KS, Hollomby DJ, House AA. Transplantation; 2003 Mar 27; 75(6):851-6. PubMed ID: 12660514 [Abstract] [Full Text] [Related]
19. Cytomegalovirus infection: its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: a single-center experience. Wadhawan M, Gupta S, Goyal N, Vasudevan KR, Makki K, Dawar R, Sardana R, Lal N, Kumar A. Liver Transpl; 2012 Dec 27; 18(12):1448-55. PubMed ID: 22903934 [Abstract] [Full Text] [Related]